1. Home/
  2. Compounds/
  3. SNX-2112:bortezomib (250:1 mol/mol)

SNX-2112:bortezomib (250:1 mol/mol)

Synonyms

SourcesNames Used
CTRPv2SNX-2112:bortezomib (250:1 mol/mol)
PharmacoGx SNX-2112:bortezomib (250:1 mol/mol)

FDA Approval Status

Not Approved
Dataset Select
Download Data as CSV

Top molecular features associated with response to SNX-2112:bortezomib (250:1 mol/mol)


Feature TypeStandardized
Nominal ANOVA
mRNA FANCE CTRPv2 pan-cancer AAC 0.087 0.01
mRNA ZDHHC9 CTRPv2 pan-cancer AAC -0.094 0.01
mRNA FEM1A CTRPv2 pan-cancer AAC 0.09 0.01
mRNA EQTN CTRPv2 pan-cancer AAC -0.082 0.01
mRNA NEURL1 CTRPv2 pan-cancer AAC -0.081 0.01
mRNA PYHIN1 CTRPv2 pan-cancer AAC 0.084 0.01
mRNA SNAPC4 CTRPv2 pan-cancer AAC 0.084 0.01
mRNA VPS36 CTRPv2 pan-cancer AAC 0.085 0.01
mRNA TMEM81 CTRPv2 pan-cancer AAC 0.086 0.01
mRNA UBE2K CTRPv2 pan-cancer AAC 0.084 0.01
Download CSV